Comparison

Anti-Adenovirus 3 [Polyclonal] - 100 µg

Item no. LEIN-18300-100ug
Manufacturer Leinco Technologies
Amount 100 ug
Category
Type Antibody Primary
Applications WB, IF, IP, IHC
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Shipping Condition Cool pack
Available
Manufacturer - Category
Antibody Products>Infectious Disease Antibodies|Primary Monoclonal Antibodies|Products
Manufacturer - Targets
Adenovirus
Shipping Temperature
Next Day 2 - 8°C
Storage Conditions
This antibody is stable for at least one (1) year at -70°C. Avoid multiple freeze- thaw cycles.
Product Description
Adenoviruses are non-enveloped, double-stranded DNA viruses that are widely distributed in nature and are a common cause of acute upper respiratory tract infections, such as the common cold. Since their discovery in 1953, 47 human adenovirus serotypes have been identified, with three known to cause gastroenteritis. While most adenoviral infections are self-limiting and present with febrile illness involving inflammation of the respiratory tract and conjunctiva, certain serotypes have demonstrated oncogenic potential in experimental models.Adenoviruses are also known to establish latent infections, particularly in lymphoid tissues such as tonsils and adenoids, from which the virus can frequently be isolated following surgical removal. The duration of viral persistence and potential for long-term reactivation remain unclear, but reactivation has been documented in immunocompromised individuals, such as those with HIV/AIDS.The early gene product E1A is one of the first viral proteins expressed following infection and serves as a potent stimulator of cellular proliferation. E1A proteins, ranging from 35 to 46 kDa, are multifunctional and capable of overcoming the growth-inhibitory effects of TGF-β. They also form complexes with critical host proteins, including the retinoblastoma (Rb) tumor suppressor, thereby disrupting cell cycle control. While E1A expression alone can immortalize primary cells, full cellular transformation requires co-expression of the E1B region, which works synergistically with E1A to drive oncogenic progression.
Manufacturer - Research Area
Infectious Disease
Concentration
Lot Specific
Formulation
Phosphate-buffered saline (PBS), pH 7.4, containing 0.02% sodium azide

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close